NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Invo Fertility, Inc. IVF
15 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$6.8M
▲ 4.7% vs FY2024
EPS · FY25
$-214.64
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-235.5%
Net margin · FY25
-340.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 6.8M
Revenue, FY2025 · full 15-year series below
Revenue
Net income
The company lost 341 cents on every revenue dollar this year.
Per share
USD -214.64
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-235.5%
Return on equity, FY2025
ROE
Operating margin-105.8%
Net margin-340.9%
Return on assets-70.4%
Each USD of equity lost 235 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+45.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+102.6%
+45.8%
+89.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years+38.5%
Change, 10 years—
The share count grew 39% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 20.2M
total assets, end of FY2025
Total assetsUSD 20.2M
EquityUSD 7.2M
Gross debtUSD 2.0M
Current ratio0.27×
Equity funds 36% of total assets.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−214.64
−3782.65
−67.37
−17.97
−0.63
−1.52
−0.45
−0.02
0.00
−0.02
−0.04
−0.02
−0.01
−0.01
−0.01
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−235.5
−137.4
·
−344.0
−102.0
−822.6
·
·
·
·
·
·
·
·
·
Shares out B
0.00
0.00
0.00
0.00
0.01
0.01
0.00
0.15
0.14
0.14
0.14
0.12
0.11
0.09
0.08
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
56 of 56
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed